Anti-parasitic drug investigated as potential COVID treatment
June 23, 2021Research and Development
The University of Oxford has announced that it has begun investigations into ivermectin, a controversial anti-parasitic drug, as a potential …
AstraZeneca’s lung cancer treatment approved in China
June 23, 2021Research and Development
AstraZeneca and HUTCHMED’s savolitinib has been granted conditional approval in China for the treatment of patients with non-small cell lung …
Extra 150 million doses of Moderna COVID jab bought by EC
June 23, 2021Research and Development
Moderna have announced that the European Commission (EC) has purchased an additional 150 million doses of their COVID-19 vaccine, bringing …
EU approves Janssen’s treatments for amyloidosis and multiple myeloma
June 23, 2021Research and Development
The EU has approved Janssen’s DARZALEX SC (daratumumab and hyaluronidase-fihj) in combination with bortezomib, cyclophosphamide, and dexamethasone for the treatment …
Vectura announces cannabinoid company collaboration for TBI treatment
June 23, 2021Research and Development
Vectura have announced the signing of a pre-clinical development agreement with Incannex, an Australian cannabinoid medicines development company, to provide …
Biotage launches new automated platform for plasmid DNA purification
June 22, 2021Manufacturing and Production
Biotage has launched PhyPrep, a new automated platform for plasmid DNA purification. With the new Biotage PhyPrep platform, the automated …
Takeda collaboration to optimise biopharmaceutical manufacturing announced
June 22, 2021Manufacturing and Production Takeda, collaboration, manufacturing
A 36-month joint project between Takeda’s manufacturing site in Vienna, the Research Center Pharmaceutical Engineering (RCPE), InSilicoTrials, and the University …
LegoChem and Iksuda expand License Agreement for antibody drug conjugates
June 22, 2021Manufacturing and Production ADC, License Agreement, deal, technology
Iksuda Therapeutics, a developer of antibody drug conjugates (ADCs), has announced the expansion of the research collaboration and License Agreement …
Insect-based vaccine production platform validated by EMA
June 22, 2021Manufacturing and Production Insect-based, Vaccine, production, technology
Algenex SL has announced EMA validation of a recombinant subunit vaccine produced by their baculovirus vector-mediated expression platform, that harnesses …
GSK’s ViiV and Halozyme to collaborate on ‘ultra-long acting’ HIV drugs
June 22, 2021Manufacturing and Production GSK, HIV, ViiV Healthcare
ViiV Healthcare, the specialist HIV company majority owned by GlaxoSmithKline (GSK), is to collaborate with Halozyme Therapeutics, giving it exclusive …
AstraZeneca ordered to deliver 50 million vaccine doses to EU
June 21, 2021Sales and Marketing
A Belgian court has instructed AstraZeneca to deliver 50 million COVID-19 shots to the European Union following a dispute on …
EU approves Onureg for patients with acute myeloid leukemia
June 21, 2021Sales and Marketing
The European Commission has approved Onureg as frontline oral maintenance therapy for patients with a broad range of acute myeloid …
Alzheimer’s drug approval: Advocacy group calls for FDA resignations
June 21, 2021Sales and Marketing
Public Citizen, the US consumer advocacy group, has called for the resignation of three top FDA officials following the approval …
Novartis’s Zolgensma for SMA shows ‘extraordinary’ results
June 21, 2021Sales and Marketing
New late-breaker data from the Phase III trial for Zolgensma, the world’s most expensive drug, has shown positive results. Zolgensma …
EU approves Aubagio for children living with MS
June 21, 2021Sales and Marketing
The EU has approved Aubagio (teriflunomide) for the treatment of paediatric patients 10 to 17 years of age with relapsing-remitting …
Breakthrough announced in circulating tumour cell research
June 18, 2021Medical Communications Cancer, Circulating tumour cells, Precision Medicine, oncology
Liquid biopsy company, Angle, has announced results from their study in non-small cell lung cancer (NSCLC) which demonstrates the benefit …
UK AI firm wins share of £140 million funding for lung cancer detection tech
June 18, 2021Medical Communications AI, CT, NHS, funding, lunch cancer, screening, technology
Artificial intelligence firm Behold.ai has won a share of £140 million in government funding for its red dot lung cancer …
Australia pauses AstraZeneca vaccine for people under 60
June 18, 2021Medical Communications AstraZeneca, Australia, COVID-19, Vaccine
Australia will now only recommend that people over 60 receive the AstraZeneca vaccine due to the rare occurrence of post-jab …
New class of cancer-killing drugs identified
June 18, 2021Medical Communications Cancer, oncology
Scientists have announced the identification of a new class of cancer drugs, known as POLQ inhibitors, that specifically kill cancer …
NICE recommends two new treatments for inflammatory arthritis
June 18, 2021Medical Communications Eli Lilly, NICE, Novartis
NICE has recommended two new treatments for axial spondyloarthritis, an underdiagnosed and debilitating type of inflammatory arthritis. Ixekizumab (also known …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
